Our findings uncover a novel mechanism by which TRIM8 promotes tumor angiogenesis by regulating tumor cell metabolism and implicates a therapeutic potential to disrupt the connection between metabolism and angiogenesis by inhibiting PGK1 K63 ubiquitination. This evidence concerns the gene PGK1 and neoplasm.